VITR and VTRLY Related Headlines
Go Back- Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement
- CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group
- Report from the Annual General Meeting of Vitrolife AB (publ)
- Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies
- Invitation to Vitrolife Group's presentation of the Q1 2026 interim report
- Notice of the Annual General Meeting of Vitrolife AB (publ)
- Vitrolife Group has today published its Annual and Sustainability Report for 2025
- Vitrolife AB (publ) - Fourth quarter and full year report 2025
- Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025
- Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment
- Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026
- Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas
- Invitation to Vitrolife Group's presentation of the Q3 2025 interim report
VITR and VTRLY Related Press Releases
Go Back- Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement
- CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group
- Report from the Annual General Meeting of Vitrolife AB (publ)
- Vitrolife AB (publ) - Interim report Q1, 2026: Strong growth in Consumables and Technologies
- Invitation to Vitrolife Group's presentation of the Q1 2026 interim report
- Notice of the Annual General Meeting of Vitrolife AB (publ)
- Vitrolife Group has today published its Annual and Sustainability Report for 2025
- Vitrolife AB (publ) - Fourth quarter and full year report 2025
- Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025
- Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment
- Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026
- Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas
- Invitation to Vitrolife Group's presentation of the Q3 2025 interim report

